This presentAtion just kicks the can further down the roAd again. I agree we have value in our pipeline and potential, but with 800 mil shares outstanding, only 17 mil cash to draw from, it points to a negative shareholder value in the short term from the current .08 cents. The long term is upward. I hope he has a rabbit in his hat today, cause if I was a buyer, I would wait til after 1-15. It mAy turn have turned me into a seller today to look for a lower entry than today.
I wonder if mentioning that RGIN was at 2/share with only one product, permDerm would cause ears to perk up. Especially since we will shortly oen that prod for a meager 12mil. Bet he doesn't mention something like this today. Seems if I wanted to demonstrate shareholder value at a steal of a price today, that's where I would start.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links